2026.05.12 Cosmax(192820) Korea Stock Analysis - Buy

📌 Company Overview

Cosmax (코스맥스, KOSPI: 192820) is South Korea's leading cosmetics ODM (Original Design Manufacturer) company, founded in 1992 and listed on KOSPI. Headquartered in Hwaseong, Gyeonggi-do, Cosmax provides end-to-end cosmetics development, formulation, and manufacturing services for global beauty brands. The company operates subsidiaries in the United States, China, Indonesia, and Australia, making it one of the most globally diversified K-beauty ODM players. Co-CEOs Choi Kyung and Lee Byung-man lead the company, which serves both domestic and international customers ranging from indie beauty brands to major conglomerates. Cosmax is widely regarded as a direct beneficiary of the global K-beauty wave.

📈 Current Stock Price

Current Price: ₩219,500 (+₩6,500, +3.05%)
(As of 2026-05-12 market close, KST)

Item Value
Closing Price₩219,500
Previous Close₩213,000
Change+₩6,500 (+3.05%)
Volume164,220 shares
52-Week High₩287,000
52-Week Low₩155,200
Distance from 52W High-23.5%
Distance from 52W Low+41.4%

🔧 Technical Analysis

Cosmax Daily Chart

Cosmax is in a clear uptrend, with the current price of ₩219,500 trading above all three major moving averages — a formation known as a golden alignment in Korean technical analysis.

Indicator Value Signal
5-Day MA₩211,900✅ Price Above
20-Day MA₩212,300✅ Price Above
60-Day MA₩195,487✅ Price Above
RSI (14)59.18Neutral (approaching bullish)
MACD5,049.89Positive
MACD Signal5,993.35
MACD Histogram-943.46⚠️ Short-term weakness
Key Support₩195,50060-Day MA zone
Key Resistance₩227,000Recent high

The RSI at 59.18 is approaching bullish territory without being overbought, suggesting room for further upside. However, the MACD histogram turning negative (-943.46) indicates short-term momentum has softened since the April high of ₩227,000. A sustained break above ₩227,000 would open the path toward the analyst target of ₩250,000. The critical support remains the 60-day MA near ₩195,500 — a close below this level would signal a trend reversal risk.

💰 Fundamental Analysis

Cosmax's financials show an accelerating growth trajectory, driven by global K-beauty demand:

Metric FY2024 FY2025 YoY Change
Revenue₩2,166.1B₩2,398.8B+10.7%
Operating Profit₩175.4B₩195.8B+11.6%
Net Income₩88.4B₩131.1B+48.3%
Total Assets₩1,933.7B₩2,125.4B+9.9%
Total Equity₩508.8B₩612.3B+20.3%
Total Debt₩1,424.9B₩1,513.1B+6.2%

Q1 2026 Highlights (Record Quarter):

  • Revenue: ₩682.0B (+15.9% YoY) — all-time quarterly record
  • Operating Profit: ₩53.0B
  • Net Income: +312% YoY surge
  • US subsidiary: +46% revenue growth
  • China subsidiary: +20% revenue growth

The debt-to-equity ratio stands at approximately 247%, which is elevated relative to lighter-asset businesses, but is typical for ODM manufacturers operating large-scale production facilities globally. Equity has grown +20.3% in FY2025, and the rapid net income growth (+48.3% in FY2025, +312% in Q1 2026) is helping to strengthen the balance sheet. Valuation is assessed as fair given the strong growth momentum.

📰 Recent News & Disclosures

All major news from May 12, 2026 centers on Cosmax's record-breaking Q1 results:

Recent DART Regulatory Disclosures:

⚖️ Bull vs Bear Factors

🐂 Bull Factors 🐻 Bear Factors
Record Q1 2026 revenue & profit (all-time quarterly high) Debt-to-equity ratio of ~247% — high financial leverage
US subsidiary +46% revenue growth, riding K-beauty global wave Current price ~23.5% below 52-week high of ₩287,000
China subsidiary +20% recovery despite challenging macro MACD histogram turned negative — short-term momentum softening
Securities firms raising target prices; foreign buying inflows Heavy reliance on sector-wide K-beauty momentum (macro risk)
Corporate Value Enhancement Plan & shareholder return commitment Profit-taking pressure after rapid rally from ₩155,200 low
National Pension Service increasing stake (institutional confidence) ODM manufacturing = capex-intensive, limits free cash flow

🎯 Investment Opinion

Rating: BUY | Confidence: Medium

Item Level Notes
Current Price₩219,500As of 2026-05-12 close
Target Price₩250,000+13.9% upside from current
Stop-Loss₩195,000Below 60-Day MA support zone
Risk/Reward~1:1.2Favorable for staged entry

Cosmax has firmly established itself as the premier K-beauty ODM representative stock, backed by an all-time quarterly earnings record and synchronized growth across Korea, the US, and China. While short-term profit-taking pressure and elevated debt levels warrant caution, the bullish moving average alignment and sustained foreign investor buying support the uptrend. A staged/partial buy approach is recommended: build positions on pullbacks toward the ₩210,000–215,000 range, with the primary target at ₩250,000 (above the prior high of ₩227,000) and a hard stop-loss at ₩195,000 (60-day MA).

For international investors, note that the KRW/USD exchange rate is an additional risk factor. Cosmax's global revenue diversification (US and China subsidiaries) does provide some natural currency hedge.

⚠️ Investment Disclaimer

This post is for informational purposes only and does not constitute investment advice. All investment decisions are the sole responsibility of the investor. Korean stock market investments involve currency risk for international investors. Past performance does not guarantee future results.


🇰🇷 Korean Version: https://kai-search.tistory.com/manage/posts/

댓글

이 블로그의 인기 게시물

2026.04.12 TS Nexgen(043220) Korea Stock Analysis - Strong Sell (Delisting Risk)

[2026-05-01] Korea Stock Market Morning Preview | Labor Day Holiday & FOMC Hold to Drive Next-Session Rebound Hopes

2026.04.15 Doosan Enerbility(034020) Korea Stock Analysis - Buy